Accelerated degradation testing and modelling have emerged as critical methodologies in reliability engineering, enabling researchers and engineers to predict product lifetimes under stressed ...
Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) on Thursday revealed clinical results from its MRT-6160 Phase 1 single ascending dose/multiple ascending dose (SAD/MAD) study. The study objectives were to ...
WASHINGTON — The Department of Veterans Affairs will launch its first clinical study since the 1960s into the effectiveness of psychedelic drugs as a treatment for post-traumatic stress disorder, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback